mercredi 30 septembre 2026
RechercherExplore
fr.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 3, 2026

Is Novo Nordisk (NYSE:NVO) Pricing Fair After A 43% One Year Share Price Decline?

View original at finance.yahoo.com
Is Novo Nordisk (NYSE:NVO) Pricing Fair After A 43% One Year Share Price Decline? Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge…
Opening lines of the source · short snapshot — read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Novo Nordisk scores 5 out of 6 on Simply Wall St's valuation checks

    60% confidence

  • Novo Nordisk DCF analysis suggests the stock is undervalued by 65.2% with an intrinsic value of US$106.21 per share compared to recent share price of US$36.98

    60% confidence

  • The DCF model shows the stock trades at a 65.2% discount to intrinsic estimate, indicating valuation materially below the model's fair value output

    60% confidence

Data points we hold from this source

Novo Nordisk A/S · free cash flow52100000000.0 DKK
Novo Nordisk A/S · year to date return-29.4 percent
Novo Nordisk A/S · 30 day return0.9 percent
Novo Nordisk A/S · valuation score5 out_of_6
Novo Nordisk A/S · 7 day return1.6 percent
Novo Nordisk A/S · projected free cash flow 2030111.09 billion_DKK
Novo Nordisk A/S · discount to intrinsic value65.2 percent
Novo Nordisk A/S · 1 year return-43.1 percent
Novo Nordisk A/S · intrinsic value dcf106.21 USD
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
The Agentic Takeover of the CFO's Office
Enterprise finance software vendors—BlackLine, OneStream, Numero AI, and Oracle—are racing to embed autonomous AI agents into core financial operations (close, consolidation, reporting), backed by consolidation M&A (Numero-Royu, BlackLine-WiseLayer), fresh leadership hires, and survey data showing nearly a quarter of CFOs plan to boost AI spending over 50%. Adoption momentum is strong even as at least one bellwether (Oracle) sees its stock lag year-to-date, suggesting the market hasn't yet fully priced in the shift from AI-as-feature to AI-as-agent in finance.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Morgan Stanley & Co. LLC
Two significantly different EPS values (10.21 vs 2.68 USD_per_share) are reported for Morgan Stanley on the same observation date (2025-12-31). Fact A specifies FY 2025, while Fact B's 'N/A' fiscal period is ambiguous. If both represent FY 2025 annual EPS, these values directly conflict. The magnitude of the difference (3.8x) is too large to attribute to rounding or minor calculation variations. The missing fiscal period in Fact B raises data quality concerns, but same-date observation + same attribute should reference the same period.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,984
faits reliés à leur source — et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,984 faits vérifiés avec la source5,315 documents sources archivés
Interrogez ces données → isubstrate.com
Is Novo Nordisk (NYSE:NVO) Pricing Fair After A 43% One Year Share Price Decline? — Source | Via News | fr.VIA.NEWS